Timeline

Hélène Saklani
																												Research Engineer
																	15 Aug 2025
								publication
									Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control.
Read more24 Sep 2015
								publication
									RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells
Read more01 Jan 2013
								
							01 Jun 2012
								publication
									Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer
Read more08 Dec 2011
								publication
									Immunization route dictates cross-priming efficiency and impacts the optimal timing of adjuvant delivery
Read more20 Feb 2009
								publication
									Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells
Read more01 Sep 2008
								publication
									Antigen persistence is required for dendritic cell licensing and CD8+ T cell cross-priming
Read more15 Jun 2006
								publication